Interaction between the new EU regulation and reimbursement

During this talk the possible effects of the new regulatory EU regulation on the reimbursement of medical devices will be explored. What are the possible effects for medical devices already being CE-registered? And which considerations from a reimbursement perspective may be there when a med-tech company will register an innovative product under the new regulation? It can be expected that there will be more synergies between CE registration and reimbursement in the future, and it is advised to take these possible synergies into account from the early start and during the design of needed clinical trials.